- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05177783
Contraception Decision Aid Use and Patient Outcomes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sarah E Hill, PhD
- Phone Number: 8172576424
- Email: s.e.hill@tcu.edu
Study Contact Backup
- Name: Summer Mengelkoch, MS
- Phone Number: 817-257-4898
- Email: s.mengelkoch@tcu.edu
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76129
- Recruiting
- Texas Christian University
-
Contact:
- Sarah Hill, PhD
- Phone Number: 512-417-5714
- Email: s.e.hill@tcu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Females 18 to 34 years of age who enroll to participate in the study, which will take place on the campus of Texas Christian University.
Exclusion Criteria:
- Women who are currently pregnant or breastfeeding.
- Women who wish to become pregnant within the next 12 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Tuune
Participants complete the Tuune contraceptive decision aid health questionnaire.
|
Participants complete the Tuune contraceptive decision aid health questionnaire.
|
|
ACTIVE_COMPARATOR: Control
Participants complete a standard physician intake health questionnaire.
|
Participants complete a standard physician intake health questionnaire.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Decisional Conflict
Time Frame: Immediately upon completion of the assigned health questionnaire.
|
Decisional conflict about contraceptive use will be measured using a modified version of the "Traditional Decisional Conflict Scale" to assess decisional conflict about birth control use. The modified version of this scale is a 13-item measure utilizing a 1-7 rating scale (1 = strongly disagree | 7 = strongly agree) asking participants about their decisional conflict with respect to birth control. Higher scores on this scale indicate less decisional conflict about birth control use. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: O'Connor AM (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25-30. doi: 10.1177/0272989X9501500105. |
Immediately upon completion of the assigned health questionnaire.
|
|
Reproductive Health Self-Efficacy
Time Frame: Immediately upon completion of the assigned health questionnaire.
|
Reproductive health self-efficacy will be measured using a modified version of the "Menstrual Attitudes Questionnaire". The modified version is a 9-item measure utilizing a 1-7 rating scale (1 = strongly disagree | 7 = strongly agree) asking participants about their menstrual cycle and hormonal self-efficacy. Higher scores indicate lower reproductive health self-efficacy. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: Brooks-Gunn, J., & Ruble, D. N. (1980). The Menstrual Attitude Questionnaire. Psychosomatic Medicine, 42(5), 503-512. https://doi.org/10.1097/00006842-198009000-00005 |
Immediately upon completion of the assigned health questionnaire.
|
|
Reproductive Health and Contraceptive Knowledge
Time Frame: Immediately upon completion of the assigned health questionnaire.
|
Reproductive health and contraceptive knowledge will be measured using the following 6-item, 1-7 rating scale (1 = strongly disagree | 7 = strongly agree). Higher scores indicate greater reproductive health and contraceptive knowledge. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ |
Immediately upon completion of the assigned health questionnaire.
|
|
Contraceptive Use Intentions
Time Frame: Immediately upon completion of the assigned health questionnaire.
|
Contraceptive use intentions will be measured by asking participants to rate their likelihood of using hormonal birth control in the next week, month, and year. Each question will be measured on a 1-7 scale (1 = extremely unlikely to use | 7 = extremely likely to use). Higher scores indicate higher use intentions. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ |
Immediately upon completion of the assigned health questionnaire.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction
Time Frame: Immediately upon completion of the primary measures.
|
Patient satisfaction with the health questionnaire will be measured using an intervention-tailored version of the "Clinical Use Satisfaction Scale". The modified version is a 14-item measure utilizing two 1-7 rating scales. Items 1 - 12 use the following rating scale: 1 = strongly disagree | 7 = strongly agree. Items 13 - 14 use the scale: 1 = very unlikely | 7 = very likely. Higher scores indicate greater satisfaction with the health questionnaire. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: Zimmerman, M., Gazarian, D., Multach, M., Attiullah, N., Benoff, T., Boerescu, D. A., ... & Holst, C. G. (2017). A clinically useful self-report measure of psychiatric patients' satisfaction with the initial evaluation. Psychiatry research, 252, 38-44. |
Immediately upon completion of the primary measures.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sarah Hill, PhD, Texas Christian University
Publications and helpful links
General Publications
- O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995 Jan-Mar;15(1):25-30. doi: 10.1177/0272989X9501500105.
- Brooks-Gunn J, Ruble DN. The menstrual attitude questionnaire. Psychosom Med. 1980 Sep;42(5):503-12. doi: 10.1097/00006842-198009000-00005.
- Zimmerman M, Gazarian D, Multach M, Attiullah N, Benoff T, Boerescu DA, Friedman MA, Mehring LB, Moon S, Patel S, Holst CG. A clinically useful self-report measure of psychiatric patients' satisfaction with the initial evaluation. Psychiatry Res. 2017 Jun;252:38-44. doi: 10.1016/j.psychres.2017.02.036. Epub 2017 Feb 20.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TCU020519781
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraceptive Usage
-
Texas Christian UniversityOklahoma State UniversityNot yet recruiting
-
Hospices Civils de LyonRecruitingContraceptive UsageFrance
-
JhpiegoCompleted
-
University of ChicagoCompleted
-
Karolinska InstitutetRecruitingContraceptive UsageSweden
-
The University of Texas at San AntonioEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Assiut UniversityCompleted
-
Nemours Children's ClinicMerck Sharp & Dohme LLCWithdrawnContraceptive Usage
-
BayerCompletedContraceptive UsageUnited States, Spain, Netherlands, Canada
-
Rutgers, The State University of New JerseyBayerSuspended
Clinical Trials on Tuune health questionnaire
-
University Hospital, LimogesUnknownInfection ViralFrance
-
Centre integre universitaire de sante et de services...Enrolling by invitationCaregivers | Health | Caregiver Wellbeing | Caregiver Mental HealthCanada
-
University Hospital, AngersWithdrawnCOVID-19 | Tonsillectomy | Adenoidectomy
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedEvaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk AssessCancer | Cancer Screening Patients | Patient VolunteersUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeUnknownMusculoskeletal Diseases | Musculoskeletal Injury
-
University of California, San DiegoNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingVaginal Stenosis | Vaginal StrictureUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Breast CarcinomaUnited States
-
Mario Negri Institute for Pharmacological ResearchIRCCS Multimedica; Centro Cardiologico MonzinoCompletedEpidemiology of Cardiovascular RiskItaly
-
Pennington Biomedical Research CenterCompleted
-
Canadian Cancer Trials GroupRecruiting